Cargando…

Prostate cancer vaccines: Update on clinical development

Prostate cancer is a common malignancy among elderly men and is essentially incurable once it becomes metastatic. Results from clinical trials testing a panel of specific vaccines in patients with castration-resistant prostate cancer (CRPC) suggest that alternative therapies may one day substitute o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geary, Sean M., Salem, Aliasger K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667918/ https://www.ncbi.nlm.nih.gov/pubmed/23762812 http://dx.doi.org/10.4161/onci.24523

Ejemplares similares

Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
por: Tambunlertchai, Supreeda, et al.
Publicado: (2022)

Potential Role of Selenium in the Treatment of Cancer and Viral Infections
por: Rataan, Aseel O., et al.
Publicado: (2022)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
por: Geary, Sean M., et al.
Publicado: (2013)

Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
por: Smith, Rasheid, et al.
Publicado: (2022)

Immunotherapy and therapeutic vaccines in prostate cancer: an update on current strategies and clinical implications
por: Singh, B Harpreet, et al.
Publicado: (2014)

Updates on Molecular and Biochemical Development and Progression of Prostate Cancer
por: Fahmy, Omar, et al.
Publicado: (2021)

Update on vaccine development for renal cell cancer
por: Chi, Nina, et al.
Publicado: (2010)

Update on Campylobacter vaccine development
por: Poly, Frédéric, et al.
Publicado: (2018)

Schistosomiasis vaccine development: update on human clinical trials
por: Molehin, Adebayo J.
Publicado: (2020)

The Absence of CpG in Plasmid DNA–Chitosan Polyplexes Enhances Transfection Efficiencies and Reduces Inflammatory Responses in Murine Lungs
por: Wongrakpanich, Amaraporn, et al.
Publicado: (2014)

Synthetically Lethal Nanoparticles for Treatment of Endometrial Cancer
por: Ebeid, Kareem, et al.
Publicado: (2017)

Statin Use in Prostate Cancer: An Update
por: Babcook, Melissa A., et al.
Publicado: (2016)

Angiogenesis Inhibition in Prostate Cancer: An Update
por: Sarkar, Chandrani, et al.
Publicado: (2020)

Genetic predisposition to prostate cancer: an update
por: Ni Raghallaigh, Holly, et al.
Publicado: (2021)

Prostate Cancer—PET Imaging Update
por: Jetty, Sankarsh, et al.
Publicado: (2023)

Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development
por: Kantor, Micaella, et al.
Publicado: (2018)

Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010)

Current status and progress of the development of prostate cancer vaccines
por: Wang, Jie, et al.
Publicado: (2023)

An Update on Self-Amplifying mRNA Vaccine Development
por: Blakney, Anna K., et al.
Publicado: (2021)

Nanotreatment and Nanodiagnosis of Prostate Cancer: Recent Updates
por: Barani, Mahmood, et al.
Publicado: (2020)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Recent update in HIV vaccine development
por: Shin, So Youn
Publicado: (2016)

Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8(+) T cells in the mouse
por: Lemke, Caitlin D., et al.
Publicado: (2011)

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
por: Rotte, Anand, et al.
Publicado: (2021)

Therapeutic efficacy of nanomedicines for prostate cancer: An update
por: Lakshmanan, Vinoth-Kumar
Publicado: (2016)

Genomic Profiling of Prostate Cancer: An Updated Review
por: Hatano, Koji, et al.
Publicado: (2022)

Recent updates on the role of microRNAs in prostate cancer
por: Hassan, Oudai, et al.
Publicado: (2012)

Update on prostate cancer in black men within the UK
por: Jones, Abeyna LC, et al.
Publicado: (2014)

Tea consumption and prostate cancer: an updated meta-analysis
por: Lin, Yi-wei, et al.
Publicado: (2014)

The AAPS Journal Theme Issue: Rising Stars in Drug Delivery and Novel Carriers
por: Salem, Aliasger K., et al.
Publicado: (2022)

COVID-19 vaccines: Update of the vaccines in use and under development
por: Marta, Rafaela Angotti, et al.
Publicado: (2022)

COVID-19 vaccines: Update of the vaccines in use and under development
por: Marta, Rafaela Angotti, et al.
Publicado: (2022)

The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
por: Silk, Natalie, et al.
Publicado: (2021)

Perspectives on the clinical development of immunotherapy in prostate cancer
por: Cordes, Lisa M, et al.
Publicado: (2018)

The Hippo Pathway in Prostate Cancer
por: Salem, Omar, et al.
Publicado: (2019)

Update on options for treatment of metastatic castration-resistant prostate cancer
por: Vishnu, Prakash, et al.
Publicado: (2010)

Update on the management of prostate cancer with goserelin acetate: patient perspectives
por: Wilson, Shandra
Publicado: (2009)

An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
por: Saxby, Helen, et al.
Publicado: (2020)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1d60ke14m1lq0v2tm5oem48i82